Prostate Cancer News on BioPortfolio

J&J raises U.S. drug prices

Johnson & Johnson raised U.S. prices on around two dozen drugs including psoriasis treatment Stelara prostate cancer drug Zytiga and blood thinner Xarelto.

J&J raises U.S. prices on around two dozen drugs

Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday including the psoriasis treatment Stelara prostate cancer drug Zytiga and blood thinner Xarelto all among its topselling products.

Obviously there are caveats and limitations with this 5Yr survival rate chart e.g. lead time bias esp in prostate and breast cancer. To be clear I'm not attributing all the gains to drugs but safe to say drugs are a big driver in many cancer types.

Obviously there are caveats and limitations with this 5Yr survival rate chart e.g. lead time bias esp in prostate and breast cancer. To be clear I'm not attributing all the gains to drugs but safe to say drugs are a big driver in many cancer types. https...

A story of missed opportunities and medical missteps

Part 2 of aÂseries. My own selfappointed role as my fathers health care advocate during his prostate cancer battle was a natural consequence of my training as a medical researcher. After earning a PhD in medical science I became the elected family health a...

Pages